|
|
|
| Research progress of leukemia complicated with epilepsy |
| WANG Wenjie1,2 LIU Jinyu1,2 CHEN Xiaoqian1,2 YAN Lingzhi3 HU Xiaowei1,2 |
1.Department of Neurology, the First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou 215006, China;
2.the First Clinical College, School of Medicine, Soochow University, Jiangsu Province, Suzhou 215006, China;
3.Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou 215006, China |
|
|
|
Abstract Leukemia is a common malignant hematological disease in the clinic, and it can induce seizures or epilepsy during the treatment. This article reviews the latest literature on leukemia complicated with epilepsy and finds that leukemia with seizures and epilepsy are mainly caused by reversible posterior encephalopathy syndrome, hematopoietic stem cell transplantation and chemotherapy. Therefore, the promotion of leukemia treatment and active prevention of seizures are of great significance for improving the prognosis of patients.
|
|
|
|
|
|
[1] Pihko H，Tyni T，Virkola K，et al. Transient ischemic cerebral lesions during induction chemotherapy for acute lymphoblastic leukemia [J]. J Pediatr，1993，123（5）：718-724.
[2] Parasole R，Petruzziello F，Menna G，et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution [J]. Leuk Lymphoma，2010，51（6）：1063-1071.
[3] Millan NC，Pastrana A，Guitter MR，et al. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia [J]. Leuk Res，2018，65（２）：86-93.
[4] de Laat P，Te Winkel ML，Devos AS，et al. Posterior reversible encephalopathy syndrome in childhood cancer [J]. Ann Oncol，2011，22（2）：472-478.
[5] Tambasco N，Mastrodicasa E，Salvatori C，et al. Prognostic factors in children with PRES and hematologic diseases [J]. Acta Neurol Scand，2016，134（6）：474-483.
[6] Nassar SL，Conklin HM，Zhou Y，et al. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia [J]. Pediatr Blood Cancer，2017，64（8）：e26 436．
[7] Khan RB，Marshman KC，Mulhern RK. Atonic seizures in survivors of childhood cancer [J]. J Child Neurol，2003，18（6）：397-400.
[8] Singer S，Grommes C，Reiner AS，et al. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer [J]. Oncologist，2015，20（7）：806-811.
[9] Khan RB，Sadighi ZS，Zabrowski J，et al. Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment [J]. Pediatr Blood Cancer，2016，63（3）：523-526.
[10] Li H，Liu Y，Chen J，et al. Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome [J]. World J Pediatr，2015，11（3）：245-249.
[11] Norman JK，Parke JT，Wilson DA，et al. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia [J]. Pediatr Blood Cancer，2007，49（2）：198-203.
[12] Won SC，Kwon SY，Han JW，et al. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases [J]. J Pediatr Hematol Oncol，2009，31（7）：505-508.
[13] Cho SG，Moon H，Lee JH，et al. Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia [J]. J Korean Med Sci，1999，14（1）：89-92.
[14] Kanda PA，Kanda RG，Mei PA，et al. Extreme Spindles and Leukoencephalopathy after Acute Lymphoblastic Leukemia Treatment：An Undescribed Association [J]. Neurodiagn J，2015，55（4）：235-242.
[15] Arhan E，Kaya Z，Serdaroglu A，et al. Successful surgical treatment of medically refractory epilepsy after chemotherapy in a child with leukemia：a case report [J]. Neurologist，2010，16（1）：41-43.
[16] Papayannidis C，Volpato F，Iacobucci I，et al. Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule [J]. Hematol Rep，2014，6（3）：5565.
[17] Chen YC，Chao TY，Chen CY，et al. Cyclosporine-induced encephalopathy in a patient with relapsed acute myeloid leukemia treated with unrelated allogeneic bone marrow transplantation [J]. J Formos Med Assoc，2000， 99（3）：248-251.
[18] La Morgia C，Mondini S，Guarino M，et al. Busulfan neurotoxicity and EEG abnormalities：a case report[J]. Neurol Sci，2004，25（2）：95-97.
[19] Robuccio A，Ssentongo P，Sather MD，et al. Intractable myoclonic seizures in an allogeneic stem cell transplant recipient：a rare case of myoclonic epilepsy [J]. Epilepsy Behav Case Rep，2015，4：48-51.
[20] Antunes NL. Seizures in children with systemic cancer [J]. Pediatr Neurol，2003，28（3）：190-193.
[21] Kang JM，Kim YJ，Kim JY，et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children：analysis of prognostic factors [J]. Biol Blood Marrow Transplant，2015，21（6）：1091-1098.
[22] Zhang XH，Xu LP，Liu DH，et al. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation：a retrospective analysis of incidence，risk factors， and survival rates [J]. Clin Transplant，2013，27（1）：80-89.
[23] Kubo M，Azuma E，Arai S，et al. Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia [J]. Pediatr Hematol Oncol，1992，9（2）：157-165.
[24] Rao RD，Swanson JW，Dejesus RS，et al. Methotrexate induced seizures associated with acute reversible magnetic resonance imaging （MRI） changes in a patient with acute lymphoblastic leukemia [J]. Leuk Lymphoma，2002， 43（6）：1333-1336.
[25] Inaba H，Khan RB，Laningham FH，et al. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer [J]. Ann Oncol，2008，19（1）：178-184.
[26] Hamamoto K，Oriuchi N，Kanazawa T，et al. Mesial temporal sclerosis associated with methotrexate-induced leuk-oencephalopathy [J]. Pediatr Neurol，2009，40（4）：306-309.
[27] Barisic N，Bilic E，Konja J. Symptomatic epilepsy associated with intracranial calcifications in children with acute lymphoblastic leukemia （ALL）[J]. Coll Antropol，2002， 26（2）：583-588.
[28] Maytal J，Grossman R，Yusuf FH，et al. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia [J]. Epilepsia，1995，36（8）：831-836.
[29] Fasano RE，Bergen DC. Intractable epilepsy in patients treated for childhood acute lymphocytic leukemia [J]. Seizure，2009，18（4）：298-302.
[30] Kasai-Yoshida E，Ogihara M，Ozawa M，et al. Temporal lobe epilepsy with hippocampal sclerosis in acute lymphoblastic leukemia [J]. Pediatrics，2013，132（1）：e252-e256.
[31] Khan RB，Morris EB，Pui CH，et al. Long-term outcome and risk factors for uncontrolled seizures after a first seizure in children with hematological malignancies [J]. J Child Neurol，2014，29（6）：774-781.
[32] Kishi S，Griener J，Cheng C，et al. Homocysteine，pharmacogenetics，and neurotoxicity in children with leukemia [J]. J Clin Oncol，2003，21（16）：3084-3091.
[33] Dierckx RA，Michotte A，Schmedding E，et al. Unilateral seizures in a patient with hairy cell leukemia treated with interferon [J]. Clin Neurol Neurosurg，1985，87（3）：209-212.
[34] Warrell RP，Berman E. Phase Ⅰ and Ⅱ study of fludarabine phosphate in leukemia：therapeutic efficacy with delayed central nervous system toxicity [J]. J Clin Oncol，1986，4（1）：74-79.
[35] Garrote H，de la Fuente A，O?觡a R，et al. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab，fludarabine and cyclophosphamide for chronic lymphocytic leukemia [J]. Exp Hematol Oncol，2015，4（1）：8.
[36] Salloum E，Khan KK，Cooper DL. Chlorambucil-induced seizures [J]. Cancer，1997，79（5）：1009-1013.
[37] Wang TY，Yen HJ，Hung GY，et al. A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia：superior sagittal sinus thrombosis [J]. J Chin Med Assoc，2011，74（4）：183-187.
[38] Aziz MA，Singh NK，Rahman MH，et al. A Young Boy with L-asparaginase-Induced Seizure [J]. Mymensingh Med J，2017，26（2）：459-461.
[39] Al-Mohsen IZ，Sutton DA，Sigler L，et al. Acrophialophora fusispora brain abscess in a child with acute lymphoblastic leukemia：review of cases and taxonomy [J]. J Clin Microbiol，2000，38（12）：4569-4576.
[40] Hamdy DA，El-Geed H，El-Salem S，et al. Posaconazole-vincristine coadministration triggers seizure in a young female adult：a case report [J]. Case Rep Hematol，2012，2012（15）：343 742.
[41] Suzuki J，Ashizawa M，Okuda S，et al. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation [J]. Transpl Infect Dis，2012，14（4）：E7-E12.
[42] Winick NJ，Bowman WP，Kamen BA，et al. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia [J]. J Natl Cancer Inst，1992，84（4）：252-256.
[43] Potter SL，Berg S，Ingle AM，et al. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia：a Children′s Oncology Group trial （P9962）[J]. Pediatr Blood Cancer，2012，58（3）：362-365.
[44] Meloni G，Nasta L，Pinto RM，et al. Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients [J]. Haematologica，1995， 80（6）：532-534.
[45] Chan KW，Mullen CA，Worth LL，et al. Lorazepam for seizure prophylaxis during high-dose busulfan administration [J]. Bone Marrow Transplant，2002，29（12）：963-965.
[46] Khan RB，Hunt DL，Thompson SJ. Gabapentin to control seizures in children undergoing cancer treatment [J]. J Child Neurol，2004，19（2）：97-101.
[47] Fukuyama T，Tanaka M，Nakazawa Y，et al. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome [J]. Pediatr Transplant，2011，15（8）：E169-E173.
[48] Xie C，Edwards H，Xu X，et al. Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia [J]. Clin Cancer Res，2010，16（22）：5499-5510.
[49] Hrebackova J，Hrabeta J，Eckschlager T. Valproic acid in the complex therapy of malignant tumors [J]. Curr Drug Targets，2010，11（3）：361-379.
[50] Graham MS，Pudusseri A，Helgager J，et al. A Woman in Her 40s with Headache and New-Onset Seizures [J]. JAMA Neurol，2017，74（4）：476-480. |
|
|
|
